IMMU-03. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA

Many immunotherapies act by enhancing the ability of T cells to kill tumor cells. But T cell killing depends on recognition of antigens presented by Class I MHC (MHC-I) on the tumor cell surface; if a tumor lacks MHC-I, it cannot be recognized by T cells. To study the efficacy of immunotherapy for G...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Garancher, Alexandra, Suzuki, Hiromichi, Haricharan, Svasti, Masihi, Meher Beigi, Rusert, Jessica M, Norris, Paula S, Carrette, Florent, Romero, Megan M, Morrissy, Sorana A, Skowron, Patryk, M.G. Cavalli, Florence, Farooq, Hamza, Ramaswamy, Vijay, J.M. Jones, Steven, Moore, Richard A, Mungall, Andrew J, Ma, Yussanne, Thiessen, Nina, Li, Yisu, Morcavallo, Alaide, Qi, Lin, Henderson, Jacob J, Crawford, John R, Levy, Michael L, Olson, James M, Cho, Yoon-Jae, Deshpande, Ani, Li, Xiao-Nan, Chesler, Louis, Marra, Marco A, Becher, Oren J, Bradley, Linda M, Ware, Carl F, Taylor, Michael D, Wechsler-Reya, Robert J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Immunology/Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477198/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados